-
EP3395339
European procedure
Extract from the Register of European Patents
EP Citations: EP3395339
| Cited in | Search | Type: | Patent literature | Publication No.: | US6211244
[YD] (VAN WAGENEN BRADFORD C [US], et al) [YD] 1-15 * abstract * * table 3 * * column 1, line 65 - column 6, line 67 *; | Type: | Patent literature | Publication No.: | US6313146
[Y] (VAN WAGENEN BRADFORD C [US], et al) [Y] 1-15 * the whole document *; | Type: | Non-patent literature | Publication information: | [Y] - ANONYMOUS, "Amgen submitted new drug application for Cinacalcet HCI", (20030908), AMGEN NEWS RELEASE, URL: http://www.amgen.com/news/news03/pressRelease030908a.pdf, (20050112), XP002313388 [Y] 1-15 * the whole document * | Type: | Non-patent literature | Publication information: | [Y] - GOODMAN WILLIAM G ET AL, "The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism.", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY : JASN. APR 2002, (200204), vol. 13, no. 4, ISSN 1046-6673, pages 1017 - 1024, XP002313387 [Y] 1-15 * the whole document * | Type: | Non-patent literature | Publication information: | [A] - ANONYMOUS, "NPS-Drug Development: Product Develpment Pipeline", (20030908), INTERNET ARTICLE, URL: www.npsp.com/drug_development/pipeline.php, (20050112), XP002313391 [A] 1-15 * the whole document * | Cited in | Opposition | Type: | Patent literature | Publication No.: | US6211244
| Type: | Patent literature | Publication No.: | US6313146
| Type: | Patent literature | Publication No.: | WO2005034928
| Type: | Patent literature | Publication No.: | EP1663182
| Type: | Patent literature | Publication No.: | EP1663182
| Type: | Patent literature | Publication No.: | US9375405
| Type: | Patent literature | Publication No.: | WO03086343
| Type: | Patent literature | Publication No.: | EP2316442
| Type: | Patent literature | Publication No.: | EP2821067
| Type: | Patent literature | Publication No.: | EP2821067
| Type: | Patent literature | Publication No.: | EP3260117
| Type: | Patent literature | Publication No.: | EP3395339
| Type: | Patent literature | Publication No.: | EP3260117
| Type: | Patent literature | Publication No.: | EP3395340
| Type: | Patent literature | Publication No.: | EP3395338
| Type: | Patent literature | Publication No.: | EP3578175
| Type: | Patent literature | Publication No.: | US6596311
| Type: | Patent literature | Publication No.: | EP1663182
| Type: | Non-patent literature | Publication information: | - FRANCESCHINI N; JOY M S; KSHIRSAGAR A, "Cinacalcet HCI: a calcimimetic agent for the management of primary and secondary hyperparathyroidism", Expert Opin Investig Drugs, (20030812), vol. 12, no. 8, pages 1413 - 1421, XP009083254 | DOI: | http://dx.doi.org/10.1517/13543784.12.8.1413 | Type: | Non-patent literature | Publication information: | - Raymond C Rowe Et Al.,, HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, Sixth Edition, Pharmaceutical Press, (20090000), pages 2pp, 129-131,185,186,208,404,581,582,691 - 692, XP055671872 | Type: | Non-patent literature | Publication information: | - GIBALDI, GIBALDI, Milo Gibaldi, Biopharmaceutics and Clinical Pharmacokinetics, fourth edition,, Lea& Febiger, (19910000), vol. 2pp, 51, XP055282823 | Type: | Non-patent literature | Publication information: | - Deodatt A Wadke, "Chapter 1 - Preformulation Testing", Deodatt A Wadke, LIEBERMAN et al., Pharmaceutical Dosage Forms: Tablets, Volume 1, 2nd ed,, (19890000), pages 1 - 24, XP055416092 | Type: | Non-patent literature | Publication information: | - Eugene F. Fiese, Timothy A. Hagen, "Preformulation", Eugene F. Fiese, Timothy A. Hagen, Leon Lachman, Herbert A Lieberman and Joseph L Kanig, The Theory and Practice of Industrial Pharmacy, Third Edition, Lea & Febiger, (19870000), pages 171-197, 298 - 303, XP055671875 | Type: | Non-patent literature | Publication information: | - "Super Disintegrants: Characterization and Function", Swarbrick J; Et Al, Encyclopaedia of Pharmaceutical Technology. Vol 20,, Marcel Dekker, (2001), pages 269 - 293, XP055512903 | DOI: | http://dx.doi.org/10.1201/b19309-12 | Type: | Non-patent literature | Publication information: | - GISSINGER D; STAMM A, "A Comparative Evaluation of the Properties of some Tablet Disintegrants", Drug Development and Industrial Pharmacy, (19800000), vol. 6, no. 5, pages 511 - 536, XP008063508 | DOI: | http://dx.doi.org/10.3109/03639048009068720 | Type: | Non-patent literature | Publication information: | - Ainley Wade, Paul J. Weller, Handbook of Pharmaceutical Excipients, Second Edition, American Pharmaceutical Association, (19940000), pages 483 - 493, XP055671886 | Type: | Non-patent literature | Publication information: | - Michael E. Aulton, Pharmaceutics: The Science of Dosage Form Design, Second Edition, Spain, Elsevier, (20020000), pages 113-138, 397 - 440, XP055671888 | Type: | Non-patent literature | Publication information: | - L. D. Quarles, et al.,, "The Calcimimetic AMG 073 as a Potential Treatment for Secondary Hyperparathyroidism of End-Stage Renal Disease", Journal of the American Society of Nephrology, (20030000), vol. 14, pages 575 - 583, XP055671891 | DOI: | http://dx.doi.org/10.1097/01.ASN.0000050224.03126.AD | Type: | Non-patent literature | Publication information: | - Anonymous, "Chemistry Review(s)", Center for Drug Evaluation and Research Application Number: 21-688, (2004), page 22pp, URL: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-688.pdf_Sensipar_Chemr.pdf, XP055671894 | Type: | Non-patent literature | Publication information: | - Anonymous, "A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis", ClinicalTrials.gov /NCT00042653/, (20020806), URL: https://clinicaltrials.gov/ct2/show/NCT00042653, XP055671896 | Type: | Non-patent literature | Publication information: | - Anonymous, "Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations", U.S. Food and Drug Administration /FDA/, URL: https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=021688&Appl_type=N | Type: | Non-patent literature | Publication information: | - ANONYMOUS, "Amgen submitted new drug application for Cinacalcet HCI", AMGEN NEWS RELEASE, (20030908), URL: http://www.amgen.com/news/n ews03/pressRelease030908a. pdf, (20050112), XP002313388 | Type: | Non-patent literature | Publication information: | - GOODMAN WILLIAM G et al., "The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism.", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY: JASN. APR 2002, (20020400), vol. 13, no. 4, ISSN 1 046-6673, pages 1017 - 1024, XP002313387 | Type: | Non-patent literature | Publication information: | - FRANCE SCHINI et al., "Cinacalcet HCI: a calcimimetic agent for the management of primary and secondary hyperparathyroidism", Expert Opin Investig Drugs, (20030000), vol. 12, no. 8, doi:10.1517/13543784.12.8.1413, pages 1413 - 21, XP009083254 | DOI: | http://dx.doi.org/10.1517/13543784.12.8.1413 | Type: | Non-patent literature | Publication information: | - QUARLES, L.D. et al., "The Calcimimetic AMG 073 as a Potential Treatment for Secondary Hyperparathyroidism of End-Stage Renal Disease", Am Soc Nephrol, (20030300), vol. 14, pages 575 - 583, XP055671891 | DOI: | http://dx.doi.org/10.1097/01.ASN.0000050224.03126.AD | Type: | Non-patent literature | Publication information: | - Anonymus, "Chapter 18: Tablets", Pharmaceutics: The Science of Dosage Form Design, (19880000), pages 304 - 305, XP055673010 | Type: | Non-patent literature | Publication information: | - Anonymus, Pharmaceutics: The Science of Dosage Form Design, (20020000), pages 404 - 408, XP055673015 | Type: | Non-patent literature | Publication information: | - L. LACHMAN et al., The theory and Practice of Industrial Pharmacy, (19860000), pages 324 - 328, XP055673018 | Type: | Non-patent literature | Publication information: | - AULTON M.E, Pharmaceutics: The Science of Dosage Form Design, New York, (19880000), pages 311 - 312, XP055673027 | Type: | Non-patent literature | Publication information: | - Remington - The Science and Practice of Pharmacy, (20000000), vol. 1, page 862, XP055673031 | Type: | Non-patent literature | Publication information: | - Anonymus, "Clinical Pharmacology and Biopharmaceutics Review. Application Number 21-688", Center for Drug Evaluation and Research, (20030905), pages 1 - 53, XP055673474 | Type: | Non-patent literature | Publication information: | - Rudolf Voigt, "Tabletten", PHARMAZEUTISCHE TECHNOLOGIE : FÜR STUDIUM UND BERUF, Stuttgart, Deutscher Apotheker Verlag, (20000101), pages 163 - 187, XP055673408 | Type: | Non-patent literature | Publication information: | - U. V. Banakar, "Factors That Influence Dissolution Testing", Pharmaceutical Dissolution Testing, (19920101), pages 136 - 145, ISBN 978-0-8247-8567-3, XP055308585 | Type: | Non-patent literature | Publication information: | - Leon Lachman, Et Al, "The Theory and Practice of Industrial Pharmacy, third edition", The Theory and Practice of Industrial Pharmacy, third edition, Lea & Febiger, (19860101), pages 189, 321 - 324-329, XP055673418 | Type: | Non-patent literature | Publication information: | - FRANCESCHINI N. et al, "CINACALCET HCI: A CALCIMIMETIC AGENT FOR THE MANAGEMENT OF PRIMARY AND SECONDARY HYPERPARATHYROIDISM", Expert Opinion on Investigational Drugs, Informa Healthcare, UK, UK, (20030101), vol. 12, no. 8, doi:10.1517/13543784.12.8.1413, ISSN 1354-3784, pages 1413 - 1421, XP009083254 | DOI: | http://dx.doi.org/10.1517/13543784.12.8.1413 | Type: | Non-patent literature | Publication information: | - Alfonso R. Gennaro, "Oral Solid Dosage Forms", REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY, (20000101), vol. 704, pages 858 - 893, XP055673423 | Type: | Non-patent literature | Publication information: | - Raymond C. Rowe et al, "Cellulose, Microcrystalline / Starch", HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, PHARMACEUTICAL PRESS, (20030529), pages 108 - 603-611, XP055673426 | Type: | Non-patent literature | Publication information: | - Kathleen M. Lee, "Unit 7.3: Overview of Drug Product Development", Current Protocols in Pharmacology, (20010101), pages 7.3.1 - 7.3.10, XP055319345 | Type: | Non-patent literature | Publication information: | - Joseph P. Remington, "Dissolution", Joseph P. Remington, Gennaro Alfonso R., Remington: the science and practice of pharmacy, Easton, Pennsylvania, Mack Publishing Company, (19950101), page 2pp, 595, ISBN 978-0-912734-04-0, XP055282825 | Type: | Non-patent literature | Publication information: | - RITSCHEL et al., "Die Tablette", (20020000), pages 332 - 335, XP55673487 | Type: | Non-patent literature | Publication information: | - Lieberman Herbert A. et al, Pharmaceutical Dosage Forms, Chapters 3 and 4, New York, Basel, Hong Kong, Marcel Dekker Inc., (19900000), vol. 1 | Type: | Non-patent literature | Publication information: | - Anonymous, "Chemistry Review(s)", Center for Drug Evaluation and Research Application Number: 21-688, page 22pp, Center for Drug Evaluation and Research Application Number: 21-688, URL: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-688.pdf_Sensipar_Chemr.pdf, (20200226), XP055671894 | Type: | Non-patent literature | Publication information: | - Anonymous, "A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis", ClinicalTrials.gov /NCT00042653/, ClinicalTrials.gov /NCT00042653/, URL: https://clinicaltrials.gov/ct2/show/NCT00042653, (20200226), XP055671896 | Type: | Non-patent literature | Publication information: | - Anonymous, "Clinical Pharmacology and Biopharmaceutics Review. Application Number 21-688", Center for Drug Evaluation and Research, (20030905), pages 1 - 53, XP055673474 | Type: | Non-patent literature | Publication information: | - Fda, "Drug approval Package: Sensipar (Cinacalcet HCI) NDA #021688", URL: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-688_Sensipar.cfm, (20200304), XP055673613 | Type: | Non-patent literature | Publication information: | - A. Wade et al, "Microcrystalline Cellulose / Crospovidone / Pregelatinized Starch", Handbook of pharmaceutical excipients, 2nd ed, (19940101), pages 84-87 - 143-144 491- 493, XP055673621 | Type: | Non-patent literature | Publication information: | - Eugene F. Fiese, Timothy A. Hagen, "Preformulation", The Theory and Practice of Industrial Pharmacy, Third Edition, Lea & Febiger, (19870101), pages 171-197 - 298-303, XP055671875 | Type: | Non-patent literature | Publication information: | - Milo Gibaldi, "Biopharmaceutics and Clinical Pharmacokinetics, fourth edition", Biopharmaceutics and Clinical Pharmacokinetics, fourth edition, Lea& Febiger, (19910101), page 2pp, 51, ISBN 978-0-8121-1346-4, XP055282823 | Type: | Non-patent literature | Publication information: | - Swarbrick J. et al, "Super Disintegrants: Characterization and Function", Encyclopaedia of Pharmaceutical Technology, Marcel Dekker, (20010101), vol. 20, pages 269 - 293, XP055512903 | DOI: | http://dx.doi.org/10.1201/b19309-12 | Type: | Non-patent literature | Publication information: | - Eugene F. Fiese et al, "Preformulation", The Theory and Practice of Industrial Pharmacy, Third Edition, Lea & Febiger, (19870101), pages 171 - 303, XP055671875 | Type: | Non-patent literature | Publication information: | - FRANCE SCHINI, N et al., "Cinacalcet HC1 : a calcimimetic agent for the management of primary and secondary hyperparathyroidism", Expert opin. Investig. Drugs, (20030000), vol. 12, no. 8, doi:10.1517/13543784.12.8.1413, pages 1413 - 1421, XP009083254 | DOI: | http://dx.doi.org/10.1517/13543784.12.8.1413 | Type: | Non-patent literature | Publication information: | - Gennaro et al., "Chapter 45 - Oral Solid Dosage Forms", Remington: The Science and Practice of Pharmacy, (2000), pages 858 - 893, XP055301374 | Type: | Non-patent literature | Publication information: | - Kathleen M Lee, "Unit 7.3: Overview of Drug Product Development", Current Protocols in Pharmacology, (20010000), pages 7.3.1 - 7.3.10, XP055319345 | Type: | Non-patent literature | Publication information: | - AULTON, "Dosage form design and manufacture", Pharmaceutics: The Science of Dosage Form Design, (20020000), pages 404 - 408, XP055673015 | Type: | Non-patent literature | Publication information: | - GOODMAN WILLIAM G et al., "The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism", Journal of the American Society of Nephrology, vol. 13, no. 4, pages 1017 - 1024, XP002387352 | Type: | Non-patent literature | Publication information: | - "Amgen Submitted New Drug Application for Cinacalcet HC1", Amgen News Release, (20030908), XP055674150 | Type: | Non-patent literature | Publication information: | - A. LE HIR, "Abrégé de pharmacie galénique formes pharmaceutiques", Abrégé de pharmacie galénique formes pharmaceutiques,, (19810000), pages 94-95,104 - 105,204-209,205-255, XP055673484 | Type: | Non-patent literature | Publication information: | - "1 Preformulation Testing", LIEBERMAN et al., Pharmaceutical Dosage Forms: Tablets volume 1, (19890000), pages 1 - 73, XP009184711 | Type: | Non-patent literature | Publication information: | - MICHAEL AULTON, "Factors influencing bioavailability: factors influencing drug absorption from the gastrointestinal tract", PHARMACEUTICS :THE SCIENCE OF DOSAGE FORM DESIGN,, (19880000), pages 135,156 - 157, XP055673473 | Type: | Non-patent literature | Publication information: | - GIBALDI, "Gastrointestinal Absorption - Physicochemical Considerations", Biopharmaceutics and Clinical Pharmacokinetics, fourth edition, (19910000), page 51, XP055282823 | Type: | Non-patent literature | Publication information: | - J.C CHAUMEIL, "Micronisation : a method for improving the bioavailability of poorly soluble drugs", Meth Find Clin. Pharmacol, (19980000), pages 211 - 215, XP055673475 | Type: | Non-patent literature | Publication information: | - FRANCESCHINI N; ET AL, "Cinacalcet HCI: a calcimimetic agent for the management of primary and secondary hyperparathyroidism", Expert Opinion on Investigational Drugs, (20030000), doi:10.1517/13543784.12.8.1413, pages 1413 - 1421, XP009083254 | DOI: | http://dx.doi.org/10.1517/13543784.12.8.1413 | Type: | Non-patent literature | Publication information: | - KLANCKE J, "Dissolution Testing of Orally Disintegrating Tablets", DISSOLUTION TECHNOLOGIES, (20030000), pages 6 - 8, XP002545423 | Type: | Non-patent literature | Publication information: | - FRANCESCHINI N. et al, "CINACALCET HCI: A CALCIMIMETIC AGENT FOR THE MANAGEMENT OF PRIMARY AND SECONDARY HYPERPARATHYROIDISM", Expert Opinion on Investigational Drugs, UK, (20030101), vol. 12, no. 8, doi:10.1517/13543784.12.8.1413, ISSN 1354-3784, pages 1413 - 1421, XP009083254 | DOI: | http://dx.doi.org/10.1517/13543784.12.8.1413 | Type: | Non-patent literature | Publication information: | - Alfonso R. Gennaro, "Oral Solid Dosage Forms", REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY, (20000101), pages 704 - 858-893, XP055673423 | Type: | Non-patent literature | Publication information: | - Raymond C. Rowe et al, "Cellulose, Microcrystalline / Starch", HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, PHARMACEUTICAL PRESS, (20030529), pages 108-111 - 603-611, XP055673426 | Type: | Non-patent literature | Publication information: | - Wolfgang A. Ritschel, Die Tablette, Handbuch der Entwicklung, Herstellung und Qualitätssicherung, 2. Auflage, Editio Cantor Verlag Aulendorf, (20020000), pages 332 - 335, XP055673487 | Type: | Non-patent literature | Publication information: | - LIEBERMAN HERBERT A. ET AL: "Pharmaceutical Dosage Forms, Chapters 3 and 4", vol. 1, 1990, MARCEL DEKKER INC., New York, Basel, Hong Kong | Type: | Non-patent literature | Publication information: | - CHAPTER16, CHAPTER16, Hans Leuenberger,, Martin . Fhysikafedte Pharmasie, (2002), pages 656 - 662, XP055784935 | Type: | Non-patent literature | Publication information: | - "crospovidone", Raymon C Rowe et al, Handbook of pharmaceutical excipients, (2006), XP055784959 | Type: | Non-patent literature | Publication information: | - "CHAPTER4", RITSCHEL W A, RITSCHEL W A Die Tablette Handbuch der Entwicklung, Herstellung und Qualitätssicherung,, (2002), pages 268 - 277, XP055274661 | Type: | Non-patent literature | Publication information: | - "15.7 Polyvinylpyrrolidon, quervernetzt", P. C. Schmidt, Tubingen et al, Wirk- und Hilffsstofffe fiir Rezeptur, Defektur und GroBherstellunq, (1999), page 267, XP055784967 | Type: | Non-patent literature | Publication information: | - "Compressed Tablets by Wet Granulation", LibermanH ET AL, Pharmaceutical Dosage Forms, (1989), pages 92,149 - 150, XP055784979 | Type: | Non-patent literature | Publication information: | - "Lactose-MonohydratLactosum monohydricum", Kommentar zur Ph. Eur. 9.0, (2017), pages 1 - 5, XP055784984 | Type: | Non-patent literature | Publication information: | - Karande, A.D. ; Heng, P.W.S. ; Liew, C.V., "In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process", INTERNATIONAL JOURNAL OF PHARMACEUTICS, (20100830), vol. 396, pages 63 - 74, XP027169573 | Type: | Non-patent literature | Publication information: | - "Magnesiumstearat", Magnesiumstearat | Type: | Non-patent literature | Publication information: | - Raymond C Rowe et al, "Croscarmellose sodium", Handbook of Pharmaceutical Excipients, (2006), pages 211-216 ,702 - 704, XP055784136 | Cited in | by applicant | Type: | Patent literature | Publication No.: | WO9304373
| Type: | Patent literature | Publication No.: | WO9418959
| Type: | Patent literature | Publication No.: | WO9511221
| Type: | Patent literature | Publication No.: | WO9612697
| Type: | Patent literature | Publication No.: | WO9741090
| Type: | Patent literature | Publication No.: | EP0933354
| Type: | Patent literature | Publication No.: | US5981599
| Type: | Patent literature | Publication No.: | US6001884
| Type: | Patent literature | Publication No.: | US6011068
| Type: | Patent literature | Publication No.: | US6031003
| Type: | Patent literature | Publication No.: | US6172091
| Type: | Patent literature | Publication No.: | US6211244
| Type: | Patent literature | Publication No.: | WO0134562
| Type: | Patent literature | Publication No.: | US6313146
| Type: | Patent literature | Publication No.: | US6342532
| Type: | Patent literature | Publication No.: | US6363231
| Type: | Patent literature | Publication No.: | US2002107406
| Type: | Patent literature | Publication No.: | US6432656
| Type: | Non-patent literature | Publication information: | - BERGE et al., J. Pharm. Sci., (19770000), vol. 66, page 1 |